Stockreport

XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XORTX Therapeutics Inc.  (XRTX) 
PDF CALGARY, Alberta, Oct. 17, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clini [Read more]